Skip to main content

Is conflict of interest becoming a challenge for institution-based institutional review boards?

Publication ,  Journal Article
Freedman, RS; McKinney, R
Published in: Clin Cancer Res
August 1, 2013

Expansion of business relationships between academic institutions and their leaders and industry have become a reality, whereas media attention regarding conflict of interest (COI) at academic institutions has raised concerns about possible erosion of public trust. The Institutional Review Board (IRB) should collaborate with institutional COI committees to ensure that research with human subjects is in compliance with various applicable federal regulations. The IRB and COI committee should take additional independent action as necessary under their separate mandates to protect the welfare, safety, and rights of human subjects and to include limits on protocols affected by significant financial interests of the institution or its decision makers. If unable to review research due to an intrainstitutional conflict, the local IRB should consider transferring the study review and oversight to an external unaffiliated institutional or central IRB. A process for involvement of an executive institutional IRB is proposed.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Cancer Res

DOI

EISSN

1557-3265

Publication Date

August 1, 2013

Volume

19

Issue

15

Start / End Page

4034 / 4039

Location

United States

Related Subject Headings

  • Research
  • Oncology & Carcinogenesis
  • Humans
  • Drug Industry
  • Drug Approval
  • Conflict of Interest
  • Commerce
  • Academies and Institutes
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Freedman, R. S., & McKinney, R. (2013). Is conflict of interest becoming a challenge for institution-based institutional review boards? Clin Cancer Res, 19(15), 4034–4039. https://doi.org/10.1158/1078-0432.CCR-13-0543
Freedman, Ralph S., and Ross McKinney. “Is conflict of interest becoming a challenge for institution-based institutional review boards?Clin Cancer Res 19, no. 15 (August 1, 2013): 4034–39. https://doi.org/10.1158/1078-0432.CCR-13-0543.
Freedman RS, McKinney R. Is conflict of interest becoming a challenge for institution-based institutional review boards? Clin Cancer Res. 2013 Aug 1;19(15):4034–9.
Freedman, Ralph S., and Ross McKinney. “Is conflict of interest becoming a challenge for institution-based institutional review boards?Clin Cancer Res, vol. 19, no. 15, Aug. 2013, pp. 4034–39. Pubmed, doi:10.1158/1078-0432.CCR-13-0543.
Freedman RS, McKinney R. Is conflict of interest becoming a challenge for institution-based institutional review boards? Clin Cancer Res. 2013 Aug 1;19(15):4034–4039.

Published In

Clin Cancer Res

DOI

EISSN

1557-3265

Publication Date

August 1, 2013

Volume

19

Issue

15

Start / End Page

4034 / 4039

Location

United States

Related Subject Headings

  • Research
  • Oncology & Carcinogenesis
  • Humans
  • Drug Industry
  • Drug Approval
  • Conflict of Interest
  • Commerce
  • Academies and Institutes
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences